Directory
>
Kate Haviland
Kate Haviland
Chief Executive Officer | Fulcrum Therapeutics
Boston, Massachusetts, United States
Kate Haviland
Summary
Kate Haviland is an accomplished executive in the biopharmaceutical and biotechnology sectors, currently serving as the Chief Executive Officer at Blueprint Medicines. With a robust background in clinical development and drug commercialization, she has played pivotal roles in leading cross-functional teams to drive innovation in the life sciences. Kate's leadership experience spans multiple high-profile organizations, including serving as Chairman of the Board at Fulcrum Therapeutics. She holds an MBA from Harvard Business School and a BA in Biochemistry/Molecular Biology and Economics from Wesleyan University, reflecting her strong academic foundation. Her expertise encompasses a wide range of areas, including oncology, infectious diseases, and medical devices. Kate is known for her strategic vision and ability to navigate complex market dynamics, making her a respected figure in the industry. In addition to her corporate roles, she has a passion for mentoring emerging leaders in biopharma.
Kate Haviland
Work Experience
Chief Executive Officer at
Blueprint Medicines
April 2022 - Present
Chairman Of The Board Of Directors at
Fulcrum Therapeutics
June 2018 - Present
Chief Operating Officer at
Blueprint Medicines
February 2019 - April 2022
Chief Business Officer at
Blueprint Medicines
January 2016 - February 2019
Vice President Rare Diseases and Oncology Program Leadership at
Aceragen
April 2014 - December 2015
Head of Commercial Development at
Sarepta Therapeutics
June 2012 - April 2014
Executive Director, Commercial Development at
PTC Therapeutics, Inc.
March 2007 - June 2012
Senior Manager at
Sanofi
January 2006 - January 2007
Principal, Corporate Development at
Sanofi
January 2005 - January 2006
Consultant at
P.A. Management en Advies B.V.
January 2000 - January 2003
Associate at
Charles River Associates
January 1998 - January 2000
Kate Haviland
Education
January 2003 - January 2005
January 1994 - January 1998
Frequently Asked Questions about Kate Haviland
What is Kate Haviland email address?
Kate Haviland's primary email address is *********@blueprintmedicines.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kate Haviland work for?
Kate Haviland is a Chief Executive Officer at Fulcrum Therapeutics, a company specializing in Commercial physical research.
Where Kate Haviland graduated from?
Kate Haviland holds a degree in from Harvard Business School.
How can I directly contact Kate Haviland?
To contact Kate Haviland directly, you can use the email address *********@blueprintmedicines.com. Complete contact information is available upon registration with Muraena.
Who is Kate Haviland?
Kate Haviland is an accomplished executive in the biopharmaceutical and biotechnology sectors, currently serving as the Chief Executive Officer at Blueprint Medicines. With a robust background in clinical development and drug commercialization, she has played pivotal roles in leading cross-functional teams to drive innovation in the life sciences. Kate's leadership experience spans multiple high-profile organizations, including serving as Chairman of the Board at Fulcrum Therapeutics. She holds an MBA from Harvard Business School and a BA in Biochemistry/Molecular Biology and Economics from Wesleyan University, reflecting her strong academic foundation. Her expertise encompasses a wide range of areas, including oncology, infectious diseases, and medical devices. Kate is known for her strategic vision and ability to navigate complex market dynamics, making her a respected figure in the industry. In addition to her corporate roles, she has a passion for mentoring emerging leaders in biopharma.
Kate`s contact details
*********@blueprintmedicines.com
*********@mba2005.hbs.edu
*********@iderapharma.com
Colleagues
Vice President, Head of Talent Acquisition & People Experience
Vice President, Head of Strategy & Program Lead
SVP, Head of Medical Affairs
Vice President
Vice President Drug Substance Process Development
Vice President, Head of Medicinal Chemistry
Chief Scientific Officer and Head of Technical Operations
Vice President Drug Safety & Pharmacovigilance
Chief Operating Officer
Chief Financial Officer